VCT Victrex plc
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; and sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, aerospace, automotive, and electronics markets, as well as engages in trading activities. It serves automotive, aerospace, energy and industrial, electronics, and medical markets. Victrex plc was incorporated in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.…
Industry Peers
Specialty ChemicalsKey Statistics
About Victrex (LON: VCT)
›
Victrex (LON: VCT) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 1,169 employees.
The shares were at 913.00 GBp on 19 November 2026, up 45.0% over 52 weeks. Its 52-week range is 515.00 GBp to 1024.00 GBp: the price is 10.8% below the high and 77.3% above the low.
Its market capitalisation is 795.76M GBP. It pays a dividend yielding 6.46% (it pays out 187% of its earnings), against a median of 1.76% among the dividend payers in that peer group.
Victrex reports return on equity of 6.4%, an operating margin of 14.3% and revenue up 0.8% year over year.
Its debt exceeds its cash by 45.40M GBP, a debt-to-equity ratio of 0.11. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 13 analysts cover the stock, with an average rating of Buy; their mean price target of 946.15 GBp is 3.6% above the current price. The next earnings report is expected on 1 December 2026.